Probi AB (publ) (PROB.ST)
SEK 347.0
(-0.29%)
SEK 347.0
(-0.29%)
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2023 | -275.85 Million SEK | -8.84% |
| 2022 | -253.43 Million SEK | -46.13% |
| 2021 | -173.42 Million SEK | -1.36% |
| 2020 | -171.1 Million SEK | -17.36% |
| 2019 | -145.79 Million SEK | -80.35% |
| 2018 | -80.83 Million SEK | -497.8% |
| 2017 | 20.32 Million SEK | -83.42% |
| 2016 | 122.55 Million SEK | 185.69% |
| 2015 | -143.02 Million SEK | -32.21% |
| 2014 | -108.18 Million SEK | -18.49% |
| 2013 | -91.3 Million SEK | -4.6% |
| 2012 | -87.28 Million SEK | -14.54% |
| 2011 | -76.2 Million SEK | 15.11% |
| 2010 | -89.76 Million SEK | -25.18% |
| 2009 | -71.7 Million SEK | -16.9% |
| 2008 | -61.34 Million SEK | -29.36% |
| 2007 | -47.42 Million SEK | -53.81% |
| 2006 | -30.83 Million SEK | 22.05% |
| 2005 | -39.55 Million SEK | 15.47% |
| 2004 | -46.78 Million SEK | -134.22% |
| 2003 | -19.97 Million SEK | -3.6% |
| 2002 | -19.28 Million SEK | 0.0% |
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2024 Q3 | -329.12 Million SEK | -23.81% |
| 2024 Q2 | -216.59 Million SEK | 24.74% |
| 2024 Q1 | -287.77 Million SEK | -4.32% |
| 2023 Q3 | -239.72 Million SEK | -1.43% |
| 2023 FY | -275.85 Million SEK | -8.84% |
| 2023 Q2 | -236.33 Million SEK | 6.13% |
| 2023 Q1 | -251.77 Million SEK | 0.66% |
| 2023 Q4 | -275.85 Million SEK | -15.07% |
| 2022 Q3 | -250.66 Million SEK | -33.33% |
| 2022 Q2 | -187.99 Million SEK | 3.84% |
| 2022 FY | -253.43 Million SEK | -46.13% |
| 2022 Q4 | -253.43 Million SEK | -1.11% |
| 2022 Q1 | -195.49 Million SEK | -12.72% |
| 2021 Q3 | -135.79 Million SEK | 31.77% |
| 2021 Q2 | -199 Million SEK | 0.16% |
| 2021 Q1 | -199.33 Million SEK | -16.5% |
| 2021 Q4 | -173.42 Million SEK | -27.71% |
| 2021 FY | -173.42 Million SEK | -1.36% |
| 2020 Q3 | -159.11 Million SEK | -20.7% |
| 2020 Q1 | -172.38 Million SEK | -18.24% |
| 2020 FY | -171.1 Million SEK | -17.36% |
| 2020 Q2 | -131.82 Million SEK | 23.53% |
| 2020 Q4 | -171.1 Million SEK | -7.54% |
| 2019 Q4 | -145.79 Million SEK | 21.46% |
| 2019 FY | -145.79 Million SEK | -80.35% |
| 2019 Q3 | -185.61 Million SEK | -48.53% |
| 2019 Q2 | -124.96 Million SEK | -13.42% |
| 2019 Q1 | -110.18 Million SEK | -36.31% |
| 2018 FY | -80.83 Million SEK | -497.8% |
| 2018 Q4 | -80.83 Million SEK | -56.67% |
| 2018 Q3 | -51.59 Million SEK | -1800.48% |
| 2018 Q2 | -2.71 Million SEK | -114.69% |
| 2018 Q1 | 18.47 Million SEK | -9.07% |
| 2017 Q4 | 20.32 Million SEK | -32.67% |
| 2017 Q1 | 72.32 Million SEK | -40.99% |
| 2017 Q3 | 30.18 Million SEK | -42.07% |
| 2017 Q2 | 52.1 Million SEK | -27.95% |
| 2017 FY | 20.32 Million SEK | -83.42% |
| 2016 FY | 122.55 Million SEK | 185.69% |
| 2016 Q1 | -153.06 Million SEK | -7.02% |
| 2016 Q3 | -967.61 Million SEK | -471.11% |
| 2016 Q2 | -169.42 Million SEK | -10.69% |
| 2016 Q4 | 122.55 Million SEK | 112.67% |
| 2015 Q1 | -126.66 Million SEK | -17.09% |
| 2015 FY | -143.02 Million SEK | -32.21% |
| 2015 Q4 | -143.02 Million SEK | 0.0% |
| 2015 Q3 | -143.02 Million SEK | -17.67% |
| 2015 Q2 | -121.54 Million SEK | 4.04% |
| 2014 FY | -108.18 Million SEK | -18.49% |
| 2014 Q4 | -108.18 Million SEK | -10.82% |
| 2014 Q2 | -94.33 Million SEK | 0.58% |
| 2014 Q1 | -94.89 Million SEK | -3.93% |
| 2014 Q3 | -97.61 Million SEK | -3.47% |
| 2013 Q3 | -91.4 Million SEK | -4.76% |
| 2013 FY | -91.3 Million SEK | -4.6% |
| 2013 Q4 | -91.3 Million SEK | 0.11% |
| 2013 Q2 | -87.24 Million SEK | 9.04% |
| 2013 Q1 | -95.92 Million SEK | -9.9% |
| 2012 Q1 | -85.91 Million SEK | -12.75% |
| 2012 Q4 | -87.28 Million SEK | -1.34% |
| 2012 Q3 | -86.12 Million SEK | -3.31% |
| 2012 Q2 | -83.36 Million SEK | 2.97% |
| 2012 FY | -87.28 Million SEK | -14.54% |
| 2011 Q3 | -75.46 Million SEK | 2.28% |
| 2011 Q2 | -77.22 Million SEK | 9.23% |
| 2011 Q4 | -76.2 Million SEK | -0.97% |
| 2011 FY | -76.2 Million SEK | 15.11% |
| 2011 Q1 | -85.08 Million SEK | 5.22% |
| 2010 Q4 | -89.76 Million SEK | 0.0% |
| 2010 FY | -89.76 Million SEK | -25.18% |
| 2009 FY | -71.7 Million SEK | -16.9% |
| 2008 FY | -61.34 Million SEK | -29.36% |
| 2007 FY | -47.42 Million SEK | -53.81% |
| 2006 FY | -30.83 Million SEK | 22.05% |
| 2005 FY | -39.55 Million SEK | 15.47% |
| 2004 FY | -46.78 Million SEK | -134.22% |
| 2003 FY | -19.97 Million SEK | -3.6% |
| 2002 FY | -19.28 Million SEK | 0.0% |
| Name | Net Debt | Net Debt Difference |
|---|---|---|
| AcuCort AB | -19.24 Million SEK | -1333.449% |
| AlzeCure Pharma AB (publ) | -29.1 Million SEK | -847.948% |
| BioGaia AB (publ) | -1.53 Billion SEK | 82.034% |
| Enzymatica AB (publ) | 17.73 Million SEK | 1655.24% |
| Enorama Pharma AB (publ) | -5.71 Million SEK | -4725.136% |
| Gabather AB (publ) | -1.11 Million SEK | -24640.179% |
| Klaria Pharma Holding AB (publ.) | 17.68 Million SEK | 1659.813% |
| Moberg Pharma AB (publ) | -55.81 Million SEK | -394.201% |
| Nanexa AB (publ) | -61.13 Million SEK | -351.212% |
| Newbury Pharmaceuticals AB (publ) | -15.3 Million SEK | -1702.607% |
| ODI Pharma AB | -2.63 Million SEK | -10357.272% |
| Orexo AB (publ) | 302.8 Million SEK | 191.101% |
| Swedencare AB (publ) | 1.42 Billion SEK | 119.408% |
| Swedish Orphan Biovitrum AB (publ) | 19.58 Billion SEK | 101.409% |
| Toleranzia AB | -17.45 Million SEK | -1480.457% |
| Vivesto AB | -1.29 Million SEK | -21135.797% |